Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Quality Improvement Vaccines Italy 2026 VAC US SMFM Maternal RSV QIRelease Date:Partner: Society for Maternal Fetal MedicineQuality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipEducation Oncology USA New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)Release Date:Education Oncology All Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate CancerRelease Date:Education Oncology All Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Title Grant Type Focus Area Country Application Due Date COVID-19 Vaccine Patient Education: Addressing Vaccine HesitancyRelease Date:Education Vaccines All Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in CanadaRelease Date:Research Rare Disease Canada Quality Improvement Grants to Support the Development of Cardiac Amyloid CentersRelease Date:Quality Improvement Rare Disease Canada Junior Investigator Transthyretin Amyloid Polyneuropathy (ATTR-PN) ResearchRelease Date:Research Rare Disease All Junior Investigator Transthyretin Amyloid Cardiomyopathy (ATTR-CM) ResearchRelease Date:Research Rare Disease All 2021 Growth Hormone Research (United States)Release Date:Research Rare Disease USA AcromegalyRelease Date:Research Rare Disease USA Pediatric Endocrinology FellowshipRelease Date:Fellowship Rare Disease USA Providing Access to Learning Resources for Tobacco Dependence TreatmentEducation Internal Medicine Bahrain, Egypt, Kuwait, Oman, Qatar, Saudi Arabia, South Africa, United Arab Emirates 2021 Global ANGPTL3 ASPIRERelease Date:Research Internal Medicine All Inflammatory Bowel Disease (Europe, Israel, Turkey, Russia, Canada, Australia, New Zealand and Japan)Release Date:Fellowship Inflammation & Immunology All Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Rare Disease USA